Symbol="CYTK"
AssetType="Common Stock"
Name="Cytokinetics Inc"
Description="Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California."
CIK="1061983"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="280 EAST GRAND AVENUE, ., SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3346490000"
EBITDA="-475224000"
PERatio="None"
PEGRatio="-0.42"
BookValue="-3.472"
DividendPerShare="0"
DividendYield="0"
EPS="-5.88"
RevenuePerShareTTM="0.105"
ProfitMargin="0"
OperatingMarginTTM="-48.43"
ReturnOnAssetsTTM="-0.388"
ReturnOnEquityTTM="-5.72"
RevenueTTM="9952000"
GrossProfitTTM="-146225000"
DilutedEPSTTM="-5.88"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.99"
AnalystTargetPrice="61.27"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.52"
PriceToBookRatio="31.9"
EVToRevenue="21.97"
EVToEBITDA="-13.92"
Beta="0.748"
num_52WeekHigh="55.8"
num_52WeekLow="30.66"
num_50DayMovingAverage="33.46"
num_200DayMovingAverage="38.17"
SharesOutstanding="95998000"
DividendDate="None"
ExDividendDate="None"
symbol="CYTK"
open="33.96"
high="35.26"
low="33.68"
price="34.86"
volume="700956.00"
latest_trading_day="2023-08-25"
previous_close="33.68"
change="1.18"
change_percent="3.5036%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="84"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="16"
Volume_recent_avg="838313"
Change_recent_avg="-0.06"
Delta_recent_avg="1.44"
Variance_recent_avg="0.72"
Change_ratio_recent_avg="-0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="16"
Aroon_momentum_negative="84"
image_negative_thumbnail_id_1="1093"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_negative_thumbnail_id_2="134"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0042.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="965"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_positive_thumbnail_id_2="609"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
